Key facts
- A National Institutes of Health (NIH) funded study on Alzheimer's disease risk in Pittsburgh has been forced to shut down due to funding cuts.
- The study, which involved 600 aging adults in two low-income, majority Black neighborhoods, was canceled in August with a 90-day shutdown notice.
- Researchers argue the cancellation, part of broader federal grant upheavals, prevents them from sharing crucial cognitive test results with participants.
- The Trump administration has canceled, frozen, or disrupted over 5,700 medical research grants funded by the NIH, impacting over 74,000 participants nationally.
- The study aimed to examine how neighborhood environments contribute to Alzheimer's risk, particularly in Black Americans who are twice as likely to suffer from the disease.
Scientific funding cuts implemented by the Trump administration have led to the premature closure of a study investigating Alzheimer's disease risk among 600 aging adults in Pittsburgh. The National Institutes of Health (NIH) canceled a federal research grant in August, providing researchers with only 90 days to cease operations, significantly earlier than the study's planned conclusion.
Researchers are concerned that the abrupt shutdown will prevent them from sharing crucial cognitive test results with participants, potentially delaying diagnoses of Alzheimer's or dementia syndromes. This is particularly critical as early diagnosis is key for treatments that can slow disease progression. The study focused on how neighborhood environments in historically red-lined, predominantly Black areas might contribute to Alzheimer's risk, a disease that disproportionately affects Black Americans.
This grant cancellation is part of a broader pattern of upheaval in federal scientific grants under the Trump administration, which has been criticized for attempting to remake science priorities and for targeting research related to diversity, equity, and inclusion (DEI). According to Grant Witness, over 5,700 NIH-funded medical research grants have been canceled, frozen, or disrupted, impacting more than 74,000 participants nationally. Researchers involved in the Pittsburgh study are also plaintiffs in a class-action lawsuit against the NIH, alleging censorship of research based on political litmus tests.
The University of Pittsburgh is actively appealing the grant cancellation, arguing that delivering results to participants is an ethical part of an orderly closeout. The administration, however, stated the grant no longer aligns with program goals or agency priorities, citing a lack of scientifically valid, measurable health outcomes. Experts warn that such grant cancellations can have severe public health consequences, especially for underserved populations facing significant health disparities.